Bayer Aktiengesellschaft (BAYRY)

Revenue

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Crop Science Revenue	21.60B	21.62B	22.26B
Crop Science Revenue Growth	-0.10%	-2.86%	-4.35%
Pharmaceuticals Revenue	17.53B	17.83B	18.13B
Pharmaceuticals Revenue Growth	-1.68%	-1.67%	0.28%
Consumer Health Revenue	5.79B	5.80B	5.87B
Consumer Health Revenue Growth	-0.14%	-1.16%	-2.60%
All Other Segment Revenue	-	302.00M	327.00M
All Other Segment Revenue Growth	-	-7.65%	37.40%
Enabling Functions and Consolidation Revenue	-	20.00M	19.00M
Enabling Functions and Consolidation Revenue Growth	-	5.26%	-9.52%
Revenue (Other)	318.00M	-	-
Revenue (Total)	45.24B	45.58B	46.61B
Revenue (Total) Growth	-0.73%	-2.21%	-2.16%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Europe/Middle East/Africa Revenue	13.18B	13.50B	13.98B
Europe/Middle East/Africa Revenue Growth	-2.39%	-3.43%	-0.75%
North America Revenue	16.95B	16.73B	16.48B
North America Revenue Growth	1.33%	1.50%	1.37%
Asia/Pacific Revenue	7.34B	7.52B	8.07B
Asia/Pacific Revenue Growth	-2.37%	-6.85%	-3.56%
Latin America Revenue	7.78B	7.83B	8.08B
Latin America Revenue Growth	-0.70%	-3.06%	-9.52%
Revenue (Total)	45.24B	45.58B	46.61B
Revenue (Total) Growth	-0.73%	-2.21%	-2.16%

Adjusted EBITDA

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Crop Science Adjusted EBITDA	4.65B	4.19B	4.33B
Crop Science Adjusted EBITDA Growth	10.91%	-3.17%	-14.15%
Pharmaceuticals Adjusted EBITDA	4.43B	4.53B	4.72B
Pharmaceuticals Adjusted EBITDA Growth	-2.21%	-4.17%	-9.00%
Consumer Health Adjusted EBITDA	1.34B	1.34B	1.37B
Consumer Health Adjusted EBITDA Growth	-0.37%	-1.83%	-3.19%
All Other Segment Adjusted EBITDA	-	277.00M	62.00M
All Other Segment Adjusted EBITDA Growth	-	346.77%	-61.96%
Enabling Functions and Consolidation Adjusted EBITDA	-	-662.00M	-352.00M
Operating Income (Total)	127.00M	-1.08B	-71.00M

Data Source: Fiscal.ai Last updated: Mar 31, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 28, 2026

Data Sources Report a data error